57 research outputs found
Recommended from our members
Research Support Services for Modern Languages and Literatures: Columbia University Libraries Local Report
This study seeks to understand the research practices of scholars in the fields of literature in modern languages, culture (including folklore, performance studies, and literary history) and writing studies. In coordination with twelve other institutions of higher education and the Modern Language Association (which sponsored the project), Columbia University Libraries partnered with Ithaka S+R, a not-for-profit educational research and consulting organization, to conduct this research. As part of Ithaka S+R’s Research and Teaching Practices stream of work, we conducted an in-depth, qualitative study of Columbia tenured and tenure-track faculty to learn more about their research interests, methods and outputs, along with their processes of discovering and accessing sources. Our local data was shared with Ithaka S+R and will inform a capstone report synthesizing findings across all institutions participating in the overall study. This humanities-based research joins the series of other disciplinary-focused reports that Ithaka S+R has coordinated.
We present our findings related to the following topics, in an order that tracks the life-cycle of research: scholars’ research focus and methodologies; sources and the search process; and research outputs. Throughout the report we refer to the roles of libraries and library staff in relation to these research practices. We hope Columbia’s local findings will contribute to a more nuanced understanding of the needs of language and literature scholars on a broad scale while surfacing important issues that can inform how we support our faculty locally. In addition, this study also raises issues that may warrant continued assessment and monitoring as we strive to align our expertise and resources with the needs and priorities of faculty
A sinvastatina melhora a cicatrização de feridas infectadas da pele de ratos
This study explores the potential of the simvastatin to ameliorate inflammation and infection in open infected skin wounds of rats. Methods: Fourteen Wistar rats weighing 285±12g were used. The study was done in a group whose open infected skin wounds were treated with topical application of sinvastatina microemulsion (SIM, n=7) and a second group with wounds treated with saline 0.9 % (SAL, n=7). A bacteriological exam of the wounds fluid for gram positive and
gram negative bacteria, the tecidual expression of TNFá and IL-1â by imunohistochemical technique, and histological analysis by HE stain were performed. Results: The expression of TNFa could be clearly demonstrated in lower degree in skin wounds treated with simvastatin (668.6 ± 74.7 ìm2) than in saline (2120.0 ± 327.1 ìm2). In comparison, wound tissue from SIM group displayed leukocyte infiltration significantly lower than that observed in SAL group (p<0.05). Culture results of the samples taken from wound fluid on fourth post treatment day revealed wound infection in only one rat of group simvastatin (SIM), where Proteus mirabilis, Escherchia coli and Enterobacter sp were isolated. In the rats whose wounds were treated with saline (SAL), polymicrobial infection with more than 100,000 CFU/g was detected in all the wounds.
Conclusion: In addition to its antiinflammatory properties, the protective effects of simvastatin in infected open skin
wounds is able to reduce infection and probably has antibacterial action. The potential to treat these wounds with statins
to ameliorate inflammation and infection is promisin
Accelerating to Zero: Strategies to Eliminate Malaria in the Peruvian Amazon.
AbstractIn February 2014, the Malaria Elimination Working Group, in partnership with the Peruvian Ministry of Health (MoH), hosted its first international conference on malaria elimination in Iquitos, Peru. The 2-day meeting gathered 85 malaria experts, including 18 international panelists, 23 stakeholders from different malaria-endemic regions of Peru, and 11 MoH authorities. The main outcome was consensus that implementing a malaria elimination project in the Amazon region is achievable, but would require: 1) a comprehensive strategic plan, 2) the altering of current programmatic guidelines from control toward elimination by including symptomatic as well as asymptomatic individuals for antimalarial therapy and transmission-blocking interventions, and 3) the prioritization of community-based active case detection with proper rapid diagnostic tests to interrupt transmission. Elimination efforts must involve key stakeholders and experts at every level of government and include integrated research activities to evaluate, implement, and tailor sustainable interventions appropriate to the region
Synthesis, characterization and thermal studies on solid state 3-methoxybenzoate of lighter trivalent lanthanides
Antibacterial properties and healing effects of Melipona scutellaris honey in MRSA-infected wounds of rats
Prática do abortamento entre adolescentes: um estudo em dez escolas de Maceió (AL, Brasil)
Plasmodium vivax malaria at households: spatial clustering and risk factors in a low endemicity urban area of the northwestern Peruvian coast
Platform for Plasmodium vivax vaccine discovery and development
Plasmodium vivax is the most prevalent malaria parasite on the American continent. It generates a global burden of 80-100 million cases annually and represents a tremendous public health problem, particularly in the American and Asian continents. A malaria vaccine would be considered the most cost-effective measure against this vector-borne disease and it would contribute to a reduction in malaria cases and to eventual eradication. Although significant progress has been achieved in the search for Plasmodium falciparum antigens that could be used in a vaccine, limited progress has been made in the search for P. vivax components that might be eligible for vaccine development. This is primarily due to the lack of in vitro cultures to serve as an antigen source and to inadequate funding. While the most advanced P. falciparum vaccine candidate is currently being tested in Phase III trials in Africa, the most advanced P. vivax candidates have only advanced to Phase I trials. Herein, we describe the overall strategy and progress in P. vivax vaccine research, from antigen discovery to preclinical and clinical development and we discuss the regional potential of Latin America to develop a comprehensive platform for vaccine development
- …